GlaxoSmithKline Revenue 2006-2020 | GSK

GlaxoSmithKline annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • GlaxoSmithKline revenue for the quarter ending September 30, 2020 was $11.169B, a 3.49% decline year-over-year.
  • GlaxoSmithKline revenue for the twelve months ending September 30, 2020 was $43.783B, a 14.46% increase year-over-year.
  • GlaxoSmithKline annual revenue for 2020 was $43.783B, a 1.58% increase from 2019.
  • GlaxoSmithKline annual revenue for 2019 was $43.1B, a 4.77% increase from 2018.
  • GlaxoSmithKline annual revenue for 2018 was $41.14B, a 5.75% increase from 2017.
GlaxoSmithKline Annual Revenue
(Millions of US $)
2020 $43,783
2019 $43,100
2018 $41,140
2017 $38,904
2016 $37,798
2015 $36,578
2014 $37,916
2013 $41,475
2012 $41,896
2011 $43,940
2010 $43,903
2009 $44,421
2008 $45,173
2007 $45,455
2006 $42,804
2005 $39,443
GlaxoSmithKline Quarterly Revenue
(Millions of US $)
2020-09-30 $11,169
2020-06-30 $9,461
2020-03-31 $11,644
2019-12-31 $11,509
2019-09-30 $11,573
2019-06-30 $10,040
2019-03-31 $9,978
2018-12-31 $6,661
2018-09-30 $10,544
2018-06-30 $9,949
2018-03-31 $13,986
2017-12-31 $10,128
2017-09-30 $10,268
2017-06-30 $9,361
2017-03-31 $9,147
2016-12-31 $9,429
2016-09-30 $9,905
2016-06-30 $9,373
2016-03-31 $8,925
2015-12-31 $9,617
2015-09-30 $9,498
2015-06-30 $9,020
2015-03-31 $8,512
2014-12-31 $9,319
2014-09-30 $9,120
2014-06-30 $9,472
2014-03-31 $9,440
2013-12-31 $11,235
2013-09-30 $10,518
2013-06-30 $10,166
2013-03-31 $9,875
2012-12-31 $10,782
2012-09-30 $10,512
2012-06-30 $10,210
2012-03-31 $10,717
2011-12-31 $10,990
2011-09-30 $11,304
2011-06-30 $10,950
2011-03-31 $10,544
2010-12-31 $11,636
2010-09-30 $10,560
2010-06-30 $9,196
2010-03-31 $11,286
2009-12-31 $13,218
2009-09-30 $11,097
2009-06-30 $10,527
2009-03-31 $9,734
2008-12-31 $10,522
2008-09-30 $11,158
2008-06-30 $11,689
2008-03-31 $11,247
2007-12-31 $12,116
2007-09-30 $11,067
2007-06-30 $11,263
2007-03-31 $10,927
2006-12-31 $11,417
2006-09-30 $10,645
2006-06-30 $10,696
2006-03-31 $10,198
2005-12-31 $10,363
2005-09-30 $9,770
2005-06-30 $9,538
2005-03-31 $9,561
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $86.243B $43.788B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $427.844B 20.27
Roche Holding AG (RHHBY) Switzerland $277.912B 0.00
Novartis AG (NVS) Switzerland $198.453B 15.05
Eli Lilly (LLY) United States $195.346B 25.70
AbbVie (ABBV) United States $189.532B 10.21
Merck (MRK) United States $188.791B 12.58
Pfizer (PFE) United States $187.985B 12.43
Novo Nordisk (NVO) Denmark $170.346B 26.31
AstraZeneca (AZN) United Kingdom $128.369B 24.21
Sanofi (SNY) $115.322B 13.67
H Lundbeck (HLUYY) Denmark $7.787B 13.77
Innoviva (INVA) United States $1.178B 5.23